skinny.

Latest / Distillations | Science History Institute

BONUS EPISODE: Pandemic Perspectives with John C. Martin

Over the next several weeks Distillations will be talking to people with special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians.

In this episode we speak with John C. Martin, a biomedical researcher and former CEO of Gilead Sciences. Gilead is a pharmaceutical giant best known for its antiviral therapies for HIV/AIDS and hepatitis, but it's also the company behind remdesivir, an antiviral drug that has recently made headlines as a possible treatment for COVID-19.

Martin talked to senior producer Mariel Carr about remdesivir…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.